compound introduction
Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC 50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. In Vitro Aganepag (Compound 3) is a potent Prostanoid EP2 receptor agonist, with an EC 50 of 0.19 nM, and shows no activity at EP4. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:EP2 0.19 nM (EC 50 )
